| Course | MPH 530 Epidemiology Concepts and Public Health Diseases (MPH/530) |
|---|---|
| Week | 4 |
| Paper type | Bias and causation paper |
| Length | about 1,187 words, 4 double-spaced pages plus title page and references |
| Format | APA 7 student paper |
| School | University of Phoenix |
| Program | MPH |
| Updated | September 2026 |
Free sample paper for MPH 530 Week 4
Is the Treatment Saving Lives or Are Healthier People Choosing It? Judging Bias, Confounding and Causation in the County's Overdose Cohort
[Student Name]
University of Phoenix
MPH/530: Epidemiology Concepts and Public Health Diseases
Week 4 Assignment
[Instructor Name]
[Date]
The county health department, its cohort and results are composites written for a model paper; research findings come from the sources cited.
The county's cohort of overdose survivors produced a headline: among 1,210 adults treated in the county's emergency departments for a nonfatal opioid overdose, those who started methadone or buprenorphine within 30 days had one-year mortality of 3.1%, compared with 5.6% among those who did not. A county commissioner read it and asked a sharp question: is the treatment saving lives, or are healthier, more motivated people the ones choosing it? This paper examines that question through bias, confounding and causal inference.
Why the Question Matters
The answer affects budgets. If treatment itself saves lives, expanding treatment starts in emergency departments is a sound investment. If the benefit mostly reflects who chooses treatment, the money might be better spent elsewhere. Getting the causal question right is a practical matter, not only an academic one.
Three Threats
Three kinds of problems can make an association misleading. Selection bias arises from how people enter or leave a study. Information bias arises from errors in measuring exposure or outcome. Confounding arises when a third factor linked to both exposure and outcome distorts the association.
A Cautionary Tale
Epidemiology has learned this lesson painfully. For years, observational studies suggested that postmenopausal hormone therapy protected women against heart disease. When a large randomized trial finally tested estrogen plus progestin, its monitoring board halted it early once harms clearly outweighed benefits; the hazard ratio for coronary heart disease was 1.29, along with higher risks of breast cancer, stroke and blood clots (Writing Group for the Women's Health Initiative Investigators, 2002). The earlier observational findings are widely attributed to confounding: women who chose hormone therapy tended to be healthier and wealthier. When the healthiest people choose a treatment, the treatment can look better than it is.
Selection Bias in the County Cohort
The cohort included only people who reached an emergency department and survived, so it cannot speak to people who died before treatment. Within the cohort, those who started treatment may differ systematically from those who did not. People who move out of state are lost to follow-up, and if movers differ in risk, estimates could be biased.
Information Bias
Treatment was measured from state prescription and program records, which are accurate for prescribed medications but miss treatment obtained outside the state. Deaths came from state death certificates, which may miss deaths out of state. Misclassification of treatment status would likely bias results toward no difference.
Confounding: The Commissioner's Concern
The commissioner's concern is confounding. People with stable housing, insurance, family support and motivation may be more likely to start treatment and less likely to die regardless of treatment. If so, part of the lower mortality reflects these factors rather than the medication.
What the Analysis Did
The epidemiologist adjusted for age, sex, insurance, housing status, prior overdoses, other substance use recorded in the emergency department and mental health diagnoses. After adjustment, the hazard ratio for death among those who started treatment was 0.58, meaning about 42% lower risk. Adjustment reduced the association only modestly, from an unadjusted ratio near 0.55.
What Adjustment Cannot Do
Adjustment handles only measured confounders. Motivation and social support were not measured directly, so residual confounding remains possible. The commissioner's question cannot be fully answered by this cohort alone.
Chance
Chance is the fourth explanation to consider. With 1,210 people and 58 deaths, the confidence interval around the adjusted hazard ratio was wide, from about 0.34 to 0.98, so the true effect could be anywhere from large to small. The interval excluded 1.0, making chance alone an unlikely explanation, but the size of the benefit is uncertain.
Effect Modification
The epidemiologist also asked whether the association differed across groups. Among people with stable housing, the benefit appeared similar to that among people who were homeless, suggesting that housing did not modify the effect, though numbers were small. Effect modification differs from confounding: it describes real differences in effect, not distortion.
Weighing Causation
Austin Bradford Hill offered nine viewpoints for deciding whether an association reflects cause, among them the size of the link, its repetition in other studies, the ordering of cause before effect, a dose-response gradient and agreement with experiments; he stressed that none is indispensable and none settles the matter alone (Hill, 1965).
Strength
A 42% reduction in mortality is a substantial association, harder to explain entirely by modest confounding.
Consistency
The Massachusetts overdose-survivor cohort described in the previous paper, far larger than the county's, found roughly half the death rate among people on methadone and about a third less among those on buprenorphine, with no association for naltrexone (Larochelle et al., 2018). The county's result is consistent with this larger study, which used similar record linkage.
Temporality
The cohort design establishes that treatment began before the deaths counted.
Biological Gradient
In the county data, people who stayed on treatment longer had lower mortality than those who stopped within a month, suggesting a dose-response relationship.
Plausibility and Coherence
Methadone and buprenorphine reduce cravings and blunt the effects of other opioids, making overdose less likely. The finding fits what is known about these medications.
Experiment and Specificity
Randomized trials have shown that these medications reduce illicit opioid use and keep people in care. Notably, naltrexone showed no association in the Massachusetts cohort; if confounding by motivation explained everything, one would expect all treatments to look protective.
Communicating Uncertainty
The epidemiologist presented the finding to the commissioners with its confidence interval and the limits described here, avoiding a headline that treatment cut deaths by 42%. Commissioners appreciated the candor; one said it made the recommendation to fund treatment more convincing, not less.
Judgment
Weighing the evidence together, the epidemiologist judged it likely that medication treatment causes much of the lower mortality, while some residual confounding probably inflates the estimate. The honest answer to the commissioner: the treatment very likely saves lives, though perhaps somewhat fewer than the raw numbers suggest.
How Large Would Confounding Have to Be
The epidemiologist estimated how strong an unmeasured confounder would need to be to erase the association entirely: it would have to roughly double the odds of starting treatment and roughly halve the risk of death, independent of the factors already adjusted for. Such a strong hidden factor is possible but seems unlikely given the adjustments made.
Further Analyses
The department will compare people who started treatment with similar people matched on propensity scores and examine whether results hold among those with stable housing only, restricting to a more homogeneous group.
Implications for Action
Public health decisions rarely wait for certainty. Given consistent evidence across studies, plausible mechanisms and the high stakes of overdose death, the department recommended expanding medication treatment starts in emergency departments while continuing to evaluate results.
Conclusion
The commissioner's skepticism was the right starting point. Selection bias, information bias and confounding could all affect the cohort's finding, and the hormone therapy story shows how confounding can reverse conclusions. Adjustment, consistency with a larger cohort, temporality, a dose-response pattern, plausibility and evidence from trials together support a cautious causal judgment.
References
Hill, A. B. (1965). The environment and disease: Association or causation? Proceedings of the Royal Society of Medicine, 58(5), 295-300. https://doi.org/10.1177/003591576505800503
Larochelle, M. R., Bernson, D., Land, T., Stopka, T. J., Wang, N., Xuan, Z., Bagley, S. M., Liebschutz, J. M., & Walley, A. Y. (2018). Medication for opioid use disorder after nonfatal opioid overdose and association with mortality: A cohort study. Annals of Internal Medicine, 169(3), 137-145. https://doi.org/10.7326/M17-3107
Writing Group for the Women's Health Initiative Investigators. (2002). Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial. JAMA, 288(3), 321-333. https://doi.org/10.1001/jama.288.3.321
What the MPH 530 Week 4 instructions ask
MPH 530 Week 4 usually asks students to explain bias, confounding and causation in epidemiologic studies. Prompts may ask students to define selection bias, information bias and confounding, identify them in a study, describe methods to prevent or control them, explain effect modification and apply criteria for causal inference such as the Bradford Hill considerations. Some versions supply a study to critique, while others let students choose one. Read your instructions for which study to use. Strong papers identify specific biases in a real study, explain the direction in which each might push results, describe design and analysis methods to address them and weigh causal criteria rather than checking them off mechanically.
How this MPH 530 Week 4 example is built
The paper opens with a county commissioner reading the cohort's headline finding and asking whether the treatment really saves lives. Selection bias, information bias and confounding are defined and applied to the cohort. The hormone therapy story shows how confounding by healthier users misled observational research until a randomized trial reversed the conclusion. The cohort's adjustment methods and remaining limits are described. The Bradford Hill considerations, including strength, consistency, temporality, dose-response and experiment, are weighed, drawing on a statewide cohort and trials. A reasoned judgment, the analyses still to come and what would change the conclusion close the paper, with advice on communicating uncertainty.
MPH 530 Week 4 grading rubric: where the points go
The bias and causation week is typically graded on correct identification of bias and confounding, understanding of how to address them and careful causal reasoning. Graders look for clear definitions, specific biases identified in a study with their likely direction, design and analytic methods to reduce them, correct use of causal criteria and a balanced judgment. A cautionary example from the literature, reported accurately, strengthens the paper considerably. Explaining what additional evidence would change the judgment, and how large residual confounding would need to be, earns credit. The final marks reflect a logical structure and APA references. Papers that list biases without applying them, or treat causal criteria as a checklist, commonly lose points.
MPH 530 Week 4 help: mistakes to avoid
MPH 530 Week 4 papers often define bias and confounding and then stop. Apply each concept to a specific study: how were people selected, how were exposures and outcomes measured and what third factors could explain the association? Say which direction each problem would push the result. Describe what was done to address it, such as restriction, matching, adjustment or randomization, and what uncertainty remains afterward. Use a well-known cautionary example, such as hormone therapy, to show how observational studies can mislead. Weigh the causal considerations together rather than checking boxes, giving more weight to temporality and experiment. Finally, reach a judgment, say how confident you are and state what evidence would change it.
Related MPH 530 sample papers
Other MPH 530 week samples
- MPH 530 Week 1: Measures of Disease Frequency
- MPH 530 Week 2: Descriptive Epidemiology
- MPH 530 Week 3: Epidemiologic Study Designs
- MPH 530 Week 5: Outbreak Investigation
- MPH 530 Week 6: Applied Epidemiologic Case Study
More MPH sample papers
MPH 530 Week 4 questions, answered
What does MPH/530 Week 4 usually ask for?
The fourth epidemiology paper typically asks students to explain bias, confounding and causation and apply them to a study, reaching a reasoned judgment about causality.
Where can I find a free MPH 530 Week 4 sample paper?
Read the overdose cohort bias paper above for free; every bias carries a note. Share the study you are critiquing, and your first paper costs nothing.
What is confounding?
A distortion of the association between an exposure and an outcome caused by a third factor that is related to both and is not on the causal pathway.
What are the Bradford Hill considerations?
Nine viewpoints proposed by Austin Bradford Hill for weighing causation, such as the size of the association, its repetition across studies, the order of exposure and outcome, a dose-response pattern and experimental support.
Why did hormone therapy research change?
Observational studies suggested hormone therapy protected against heart disease, but a large randomized trial found higher risk of coronary events, likely because healthier women had chosen hormone therapy in observational studies.
Write yours, or have the desk draft it
This paper is an original model document written by our desk, not a submitted student paper and not an official University of Phoenix document. Read it for the moves, then write your own to the instructions in your classroom. If you want one built to your exact prompt and rubric, the first custom sample is free and arrives in 24 to 48 hours.
Request this one custom, free · All MPH 530 week samples · All courses